ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,887 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentGlattbruggOtsuka Pharmaceutical (Switzerland) GmbH
Otsuka Pharmaceutical (Switzerland) GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Otsuka Pharmaceutical Europe Ltd. is the development, manufacture and marketing of pharmaceutical products and nutritional supplements (Nutraceuticals) to improve the health and well-being of people worldwide.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Otsuka Pharmaceutical (Switzerland) GmbH

✓ Offered6
Therapeutic areas
Neuroscience, Haemato-Oncology, Nephrology and Immunology, as well as Infectious Diseases; development of treatments for schizophrenia, bipolar disorder, AML, ADPKD, lupus nephritis, hereditary angioedema, IgA nephropathy and tuberculosis.
Medicines in Europe
Medicines for Europe; country-specific availability, local contact information for product availability, and points of contact for medical information and adverse event reporting.
Research and Development
Research and Development in global therapeutic areas such as Neurology, Oncology, Cardiology, Nephrology, Gastroenterology, Infectious Diseases, Ophthalmology and Dermatology; also digital health technologies.
Clinical studies
Public availability of information on clinical studies via the EU Clinical Trials Register, ClinicalTrials.gov and NIPH Clinical Trials Search.
Medical information
Answers to questions about Otsuka products provided by Medical Information Specialists; telephone and written enquiries, with a response depending on complexity within five working days.
Adverse event reporting
Reporting of unwanted events and side effects for healthcare professionals and the public; safety surveillance for all products.
Trust & reputation

ranQ Trust Score of Otsuka Pharmaceutical (Switzerland) GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Otsuka Pharmaceutical (Switzerland) GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Otsuka Pharmaceutical (Switzerland) GmbH scores 84.7 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.95.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Otsuka Pharmaceutical (Switzerland) GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Otsuka Pharmaceutical (Switzerland) GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Otsuka Pharmaceutical (Switzerland) GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Otsuka Pharmaceutical (Switzerland) GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Otsuka Pharmaceutical (Switzerland) GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Otsuka Pharmaceutical (Switzerland) GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Otsuka Pharmaceutical (Switzerland) GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Sägereistrasse 20
8152 Glattbrugg

At a glance

Legal form
Limited Liability Company
UID
CHE-174.961.683
Founded
2013 · 13 years
Last commercial register change
June 22, 2023
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.88.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    FO
    Five Office Ltd
    Wetzikon Zh 1
    FS
    Fortrea Switzerland AG
    Zurich
    SH
    Syneos Health Switzerland GmbH
    Zurich
    NA
    Neurimmune AG
    Schlieren
    IG
    Illusonic GmbH
    Greifensee
    PG
    ProPharma Group Switzerland GmbH
    Zurich
    CS
    Celerion Switzerland AG
    Fehraltorf
    NM
    NanoFLOWCELL Management AG
    Kilchberg Zh